Metronidazole News and Research

RSS
ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Alcohol and antibiotics: an interview with Dr Randall

Alcohol and antibiotics: an interview with Dr Randall

Is it safe to drink alcohol when taking antibiotics?

Is it safe to drink alcohol when taking antibiotics?

C. diff infections on the rise among children, elderly

C. diff infections on the rise among children, elderly

Novel therapy that uses human stool is safe and highly effective in treating C.diff infection

Novel therapy that uses human stool is safe and highly effective in treating C.diff infection

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

RA drug effective against Entamoeba histolytica

RA drug effective against Entamoeba histolytica

Auranofin effective against amoebas in lab and animal studies

Auranofin effective against amoebas in lab and animal studies

New diagnostic test for Trichomonas vaginalis

New diagnostic test for Trichomonas vaginalis

Cancer patients with CDI may benefit from DIFICLIR drug

Cancer patients with CDI may benefit from DIFICLIR drug

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Australians discover treatment for very common female infection

Australians discover treatment for very common female infection

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

China Sky One Medical first quarter total revenue decreases 1.9% to $28.4 million

China Sky One Medical first quarter total revenue decreases 1.9% to $28.4 million

Scientists develop new test for premature babies

Scientists develop new test for premature babies

Optimer, Cubist sign deal to market DIFICID for CDI treatment in the U.S.

Optimer, Cubist sign deal to market DIFICID for CDI treatment in the U.S.